Urovant’s new overactive bladder (OAB) drug Gemtesa (vibegron) is approved by the FDA
… Urovant’s New Overactive Bladder Drug Gemtesa (vibegron) is FDA approved …

UROVANT’S NEW OAB DRUG GEMTESA (vibegron) EARNS FDA APPROVAL

Urovant’s First FDA Approved Drug

The approval of Gemtesa is a strategic corporate milestone for Urovant

  • Botox (AbbVie)
  • Enablex (available as a generic)
  • Vesicare (available as a generic)
  • Toviaz (Pfizer)

Urovant is a business unit of a larger global conglomerate